CAPRICOR THERAPEUTICS, INC.
Company Stats
- Market Cap
- $550.6M
- as of Sep 30, 2026
- Shares Outstanding
- 58.1M
- Free Float
- 42.5%
Income Statement
- Revenue
- $0
- Operating Income
- -$108.1M
- Net Income
- -$105.0M
- EBITDA
- -$106.3M
Cash Flow
- Free Cash Flow
- -$72.7M
- FCF Yield
- -13.2%
- Owner FCF Yield
- -16.3%
Balance Sheet
- Cash & Equivalents
- $287.8M
Returns & Capital
- SBC, 3Y Avg
- $11.5M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $0 | -$72.7M | — |
| FY2024 | $22.3M | -$41.2M | -184.8% |
| FY2023 | $25.2M | -$26.9M | -106.9% |
| FY2022 | $2.6M | $2.9M | 114.3% |
| FY2021 | $244,898 | -$18.0M | -7352.3% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 10, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges